title: Prulifloxacin.
authors.affiliation: Adis International Limited, Auckland, New Zealand. demail@adis.co.nz
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Keam
authors.forename: Caroline M
authors.initials: CM
authors.lastname: Perry
mesh_terms: D000284:Administration, Oral; D000658:Amoxicillin / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D029481:Bronchitis, Chronic / Q000150:complications / Q000188:drug therapy; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000494:pharmacology; D004148:Dioxolanes / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000145:classification / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D007558:Italy; D015394:Molecular Structure; D009520:New Zealand; D010879:Piperazines / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D011355:Prodrugs / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy; D015366:Pefloxacin
chemical_list: D000658:Amoxicillin; D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D019818:Clavulanic Acid; D004148:Dioxolanes; D024841:Fluoroquinolones; D010879:Piperazines; D011355:Prodrugs; D015363:Quinolones; D015366:Pefloxacin; C074190:ulifloxacin; C074191:prulifloxacin